For instance, reduced BIN1 expression collaborates with RAS activation to promote tumor progression in breast cancer, highlighting BIN1’s role as a negative regulator of breast cancer carcinogenesis and progression [18]. The gene discussed is BIN1; the disease is neoplasm.